Quality AssuranceEvaluating the Purity Thresholds: Why 95% is Not Enough for In-Vitro Assays
95% sounds high until impurities hijack your receptors. Data-driven case for 99% thresholds in serious bench work.
Read full article →NovaSynth Scientific Media
No fluff, just facts — peer-style guidance on peptide QC, receptor pharmacology, shipping compliance, and wholesale sourcing from working laboratory scientists.
17 research articles · full media library
Quality Assurance95% sounds high until impurities hijack your receptors. Data-driven case for 99% thresholds in serious bench work.
Read full article →
SynthesisYour antibody is only as good as its antigen. Custom peptide synthesis for mAb workflows—from epitope prediction to KLH conjugation.
Read full article →
IndustryGlobal collaborations fail when peptide provenance is opaque. Transparency is becoming a grant requirement—not a nice-to-have.
Read full article →
Protocols−20 °C is the default, but default is not optimal. Bench protocols for maximizing peptide reagent shelf life.
Read full article →
SynthesisSPPS built the peptide research world; LPPS and hybrid flows are scaling it. Bench scientist's tour of how your vials get made.
Read full article →
ResearchGIP is not 'GLP-1 lite.' Dual-agonist reagents force us to rethink bias, coupling, and tissue-specific receptor expression models.
Read full article →
Quality AssuranceTFA makes peptides HPLC-friendly and cells unhappy. Here is how purification finishing steps determine whether your reagent is cell-culture ready.
Read full article →
ResearchCagrilintide is not a footnote to semaglutide—it is a synergistic partner in satiety pathway research. How to design combination assays.
Read full article →
ComplianceRUO is not a loophole—it is a compliance boundary. Updated 2026 guidance for PIs, IACUC, and biosafety officers.
Read full article →
ProcurementSingle-vial markups can exceed 400% over bulk mg pricing. Here is how labs should model total cost of ownership for peptide reagents.
Read full article →
LogisticsLyophilized peptides are not indestructible, but the science explains why most vials survive international shipping when packaged correctly.
Read full article →
Quality AssuranceA COA is not decorative PDF wallpaper. Learn to spot fake specs, missing methods, and impurity peaks that will wreck your assays.
Read full article →
ResearchLY3437943 is not just another GLP-1 analog—it is a tri-agonist rewriting how we model incretin biology in vitro. Bench-focused mechanistic primer.
Read full article →
LogisticsCustoms paperwork, IATA Class 6.2 exemptions, and reshipment policies separate reliable peptide logistics from lost shipments. No marketing—just operational reality.
Read full article →
Quality AssuranceSemaglutide and tirzepatide demand ≥99% area-under-curve purity—not marketing fluff. Here is how synthesis, SPPS, and HPLC validation actually work on the bench.
Read full article →
GLP-1 ResearchSemaglutide is everywhere in metabolic research right now. Here is what that actually means on the bench, without the hype cycle.
Read full article →
SourcingReview hubs and success-story threads are noisy. Here is a practical filter for lab buyers who actually need reproducible material.
Read full article →Secure Checkout
No items yet. Tap SELECT on any product to add.